https://orcid.org/0000-0003-2985-482X
References
- Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557–573. doi:10.1016/j.jacc.2008.10.041
- Shin JT, Dec GW. Ultrafiltration should not replace diuretics for the initial treatment of acute decompensated heart failure. Circ Heart Fail. 2009;2:505–511. doi:10.1161/circheartfailure.109.862474
- Jessup M, Abraham WT, Casey DE; 2009 Writing Group to Review New Evidence and Update the 2005 Guideline for the Management of Patients with Chronic Heart Failure Writing on Behalf of the 2005 Heart Failure Writing Committee. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977–2016. doi:10.1161/CIRCULATIONAHA.109.192064
- Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis. Ann Intern Med. 1985;103:1–6. doi:10.7326/0003-4819-103-1-1
- Francis G. Acute decompensated heart failure: the cardiorenal syndrome. Ann Intern Med. 2006;73:S8.
- Mielniczuk L, Stevenson LW. Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials? Curr Opin Cardiol. 2005;(4):529–534. doi:10.1097/01.hco.0000167721.22453.9c
- Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). JACC CardioOncol. 2005;46:e1–82. doi:10.1016/j.jacc.2005.08.022
- Goodman LS. Goodman and Gilman’s manual of pharmacology and therapeutics. Mcgraw Hill Professional; 2008.
- Mentz RJ, Stevens SR, DeVore AD, et al. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC Heart Fail. 2015;3:97–107. doi:10.1016/j.jchf.2014.09.003
- Davies MK, Gibbs CR, Lip GY. Management: diuretics, ACE inhibitors, and nitrates. BMJ. 2000;320:428–431. doi:10.1136/bmj.320.7232.428
- Metra M, Cotter G, Gheorghiade M, et al. The role of the kidney in heart failure. Eur Heart J. 2012;33:1242–2135. doi:10.1093/eurheartj/ehs205
- Damman K, Navis G, Voors AA, et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13:599–608. doi:10.1016/j.cardfail.2007.04.008
- Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797–805. doi:10.1056/nejmoa1005419
- Ruggenenti P, Remuzzi G. Worsening kidney function in decompensated heart failure: treat the heart, don’t mind the kidney. Eur Heart J. 2011;32:2476–2478. doi:10.1093/eurheartj/ehr242
- Ronco C, Bellasi A, Di Lullo L. Implication of acute kidney injury in heart failure. Heart Fail Clin. 2019;15:463–476. doi:10.1016/j.hfc.2019.05.002
- Metra M, Torp‐Pedersen C, Cleland JG, et al. Should beta‐blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Failure. 2007;9:901–909. doi:10.1016/j.ejheart.2007.05.011
- Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810–1852. doi:10.1161/cir.0b013e31829e8807